Pure Global

Varicella-Zoster Virus IgG - India CDSCO Medical Device Registration

Varicella-Zoster Virus IgG is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/001078_913c01421088b405473848e48429ad14_00e03cf9d550d46e9aa5a8bbf09541b1. This device is marketed under the brand name NovaLisa®. The license holder is OSB Agencies Private Limiated, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Varicella-Zoster Virus IgG
UID: IMP/IVD/2020/001078_913c01421088b405473848e48429ad14_00e03cf9d550d46e9aa5a8bbf09541b1

Brand Name

NovaLisa®

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Varicella-Zoster Virus (NovaLisa®) IgG ELISA is intended for the qualitative determination of IgG class antibodies against Varicella-Zoster Virus (NovaLisa®) in human serum or plasma (NovaLisa®)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing